ENDIA
ENDIA (Environmental Determinants of Islet Autoimmunity) is a significant research study aimed at understanding the environmental factors that contribute to the development of Type 1 diabetes (T1D). T1D is an autoimmune condition where the body's immune system attacks the insulin-producing beta cells in the pancreas, leading to a lifelong dependency on insulin injections. The ENDIA study is pioneering in its approach to identify the environmental exposures that may influence the risk of developing T1D in early life, from pregnancy through to early childhood.
Background
The incidence of Type 1 diabetes has been increasing worldwide, suggesting that changes in the environment play a crucial role in the rising prevalence. Genetic predisposition cannot solely explain this increase, as the genetic makeup of populations does not change significantly over short periods. This observation has led researchers to investigate the environmental determinants of T1D, with the ENDIA study being at the forefront of this research.
Study Design
The ENDIA study is a longitudinal cohort study that enrolls pregnant women who have a family history of T1D, either themselves or through the child's biological father or sibling. The study follows the offspring from pregnancy through to early childhood, collecting detailed information and biological samples at various stages. This comprehensive approach allows researchers to examine how environmental factors, such as diet, viral infections, gut microbiota, and exposure to toxins, may influence the development of islet autoimmunity and T1D.
Objectives
The primary objective of the ENDIA study is to identify environmental exposures that are associated with the development of islet autoimmunity and T1D in children at risk. By understanding these environmental triggers, the study aims to inform strategies for the prevention of T1D in the future.
Findings and Implications
While the ENDIA study is ongoing, preliminary findings have highlighted the complexity of T1D development and the interplay between genetic susceptibility and environmental exposures. Insights from the study are expected to contribute significantly to the understanding of T1D pathogenesis and to the development of preventive strategies.
Conclusion
The ENDIA study represents a critical effort in the quest to unravel the environmental determinants of Type 1 diabetes. By focusing on the early life stages, from pregnancy to early childhood, the study offers the potential to identify modifiable risk factors that could lead to the prevention of T1D in future generations.
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
